Gerhild van Echten-Deckert Selected Research

Gerhild van Echten-Deckert Research Topics

Disease

6	Neuroblastoma 11/2007 - 08/2002
3	Lymphoma (Lymphomas) 08/2010 - 01/2003
2	Inflammation (Inflammations) 10/2019 - 09/2006
2	Alzheimer Disease (Alzheimer's Disease) 06/2014 - 10/2012
2	Reperfusion Injury 01/2013 - 01/2009
2	Ischemia 01/2013 - 01/2009
2	Ileus 11/2010 - 09/2006
1	Neoplasms (Cancer) 12/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Mental Disorders (Mental Disorder) 01/2020
1	Neuroinflammatory Diseases 01/2020
1	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2017
1	Death (Near-Death Experience) 04/2014
1	Dementia (Dementias) 10/2013
1	Insulin Resistance 07/2012
1	Multiple Sclerosis 03/2011
1	Inborn Genetic Diseases (Disease, Hereditary) 04/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2008
1	Oncogene Addiction 02/2008
1	Lymphopenia (Lymphocytopenia) 12/2004
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2003

Drug/Important Bio-Agent (IBA)

8	SphingolipidsIBA 12/2021 - 09/2006
5	Proteins (Proteins, Gene)FDA Link 06/2014 - 08/2002
4	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 10/2019 - 12/2002
3	SphingosineIBA 01/2017 - 12/2002
2	ectoineIBA 01/2021 - 01/2013
2	LipidsIBA 01/2020 - 04/2008
2	Amyloid (Amyloid Fibrils)IBA 06/2014 - 10/2012
2	Fingolimod Hydrochloride (FTY720)FDA Link 03/2011 - 12/2004
2	Tyrosine (L-Tyrosine)FDA Link 08/2010 - 02/2008
2	Phosphotransferases (Kinase)IBA 08/2010 - 02/2008
1	CytokinesIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	sphingosine 1-phosphate lyase (aldolase)IBA 01/2017
1	CholesterolIBA 01/2017
1	LyasesIBA 01/2017
1	hydroxyectoineIBA 04/2014
1	dicarboxydine (DCD)IBA 04/2014
1	Flavin-Adenine Dinucleotide (FAD)IBA 10/2013
1	Peptides (Polypeptides)IBA 10/2012
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2012
1	Membrane LipidsIBA 10/2012
1	AdipokinesIBA 07/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2012
1	Pharmaceutical PreparationsIBA 03/2011
1	Sphingosine-1-Phosphate ReceptorsIBA 03/2011
1	EnzymesIBA 08/2010
1	Anaplastic Lymphoma KinaseIBA 08/2010
1	Transcription Factors (Transcription Factor)IBA 08/2010
1	GlycosphingolipidsIBA 08/2010
1	Carboxylic AcidsIBA 01/2009
1	GangliosidesIBA 04/2008
1	GlycosyltransferasesIBA 04/2008
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 02/2008
1	TrichothecenesIBA 11/2007
1	Messenger RNA (mRNA)IBA 11/2007
1	ProdrugsIBA 12/2004
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2004
1	safingol (sphinganine)IBA 09/2003
1	erythro-dihydrosphingosineIBA 09/2003
1	1-methylthiodihydroceramideIBA 03/2003
1	SodiumIBA 03/2003
1	polyacrylamideIBA 03/2003
1	Rituximab (Mabthera)FDA Link 01/2003
1	Mitogen-Activated Protein KinasesIBA 12/2002
1	Phosphates (Orthophosphate)IBA 12/2002
1	CeramidesIBA 08/2002

Therapy/Procedure

2	Transplantation 01/2013 - 01/2009
1	Organ Transplantation 01/2021
1	Aftercare (After-Treatment) 12/2002